SCHEMBL13626575

SCHEMBL13626575

CCN(c1cc(OC)ccc1C1CCc2cc(O)ccc2C1)C(C)c1ccc(OCCNC2CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
KDM4E B2RXH2 3/20 0.38
DRD2 P14416 4/20 0.36
DRD3 P35462 4/20 0.36
SLC6A4 P31645 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
DRD4 P21917 1/20 0.36
CYP26A1 O43174 1/20 0.35
GRIN2B Q13224 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GRIN1 Q05586 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626576 0.96 ESR1 (0.52) ESR1ESR2KDM4EDRD2DRD3
SCHEMBL13626574 0.92 ESR1 (0.53) ESR1ESR2DRD2DRD3HRH3
SCHEMBL13626578 0.91 ESR1 (0.54) ESR1ESR2DRD2DRD3DRD4
SCHEMBL13626600 0.90 ESR1 (0.51) ESR1ESR2DRD2DRD3SLC6A4
SCHEMBL13626588 0.90 ESR1 (0.51) ESR1ESR2DRD2DRD3SLC6A4
SCHEMBL13626577 0.89 ESR1 (0.53) ESR1ESR2DRD2DRD3DRD4
SCHEMBL13626589 0.88 ESR1 (0.51) ESR1ESR2KDM4EDRD2DRD3
SCHEMBL13626580 0.88 ESR1 (0.52) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL228966 0.88 ESR1 (0.58) ESR1ESR2KDM4EDRD2DRD3
SCHEMBL13626586 0.87 ESR1 (0.48) ESR1ESR2KDM4EDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed